HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

890.299

+11.5091.31%

Number of Gainers:10

Number of Losers:7

Number of Flat:- -

PE:- -

High:890.563

Open:876.263

Low:869.207

Close:878.789

Volume:258.00M

Turnover:2.03B

Market Cap:600.24B

Float Cap:496.87B

Loading ...

Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale

Dizhe Pharma Stock Drops Over 5% After Insider Sell-Off Plan; Company Affirms Long-Term Confidence

ALEBUND-B (09637) H Shares Set to Join Stock Connect and Hang Seng Composite Index

Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping

Junshi Biosciences Schedules 2026 Interim Results Conference Call

Traditional Chinese Medicine Firm Secures Regulatory Approval for New Depression Treatment

China Traditional Chinese Medicine Says NMPA Approves Launch of Xingpi Jieyu Tablets for Depression

China Traditional Chinese Medicine Holdings - Nmpa Approves Xingpi Jieyu Tablets for Marketing

THOMSON REUTERS

Sinopharm Group Stock Advances 1.5% in Hong Kong

JD Health International Stock Rallies 2.9% in Hong Kong

Alibaba Health Information Technology Stock Climbs 3.3% in Hong Kong

DBS lifts BYD Electronic price target to HK$40, reiterates 'Buy'

Healthcare Sector Poised for Continued Recovery, Buoyed by Strong Innovation and Upgraded Earnings Forecasts

Hong Kong Stock Exchange Data Reveals Significant Custody Transfer for GENFLEET-B

Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug

MT Newswires Live

Baiyunshan Announces Cash Dividend Distribution for First Half of 2026

Sino Biopharm Says FDA Clears IND for Tqb6426 GPC3 ADC Trial in Advanced Tumors

Sino Biopharmaceutical - Application for Clinical Trial on Tqb6426 "Gpc3 ADC" Approved by FDA

THOMSON REUTERS

Executive Wang Lei Boosts Stake in China Resources Mixc Lifestyle with Fresh Share Purchase

GENFLEET-B Allocates HK$546,400 to Buy Back 20,000 Shares on September 3

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK1515/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":890.2986,"timestamp":1789373135071,"preClose":878.7892,"halted":0,"volume":257997054,"delay":0,"changeRate":0.013097,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closing Auction","change":11.509399,"latestTime":"09-14 16:00:00","open":876.263,"high":890.56287,"low":869.2073,"amount":2032489965,"amplitude":0.024301,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789373400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"pbRate":1.318473,"peRate":17.086203,"turnoverRate":0.003534,"increases":11,"decrements":6,"flats":0,"marketCap":600236234944,"floatMarketCap":496865354048},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":890.56287,"amplitude":0.024301,"preClose":878.7892,"low":869.2073,"pbRate":"1.318473","latestPrice":890.2986,"volume":257997054,"delay":0,"open":876.263,"prevYearClose":1190.107,"prevWeekClose":878.789,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":942.123,"twentyDayClose":915.795,"sixtyDayClose":842.862,"secType":"PLATE","market":"HK","turnoverRate":0.003534,"peRate":17.086203,"marketCap":600236234944,"floatMarketCap":496865354048,"timestamp":1789373135071,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":10,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1120592433","title":"Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1120592433","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120592433?lang=en_us&edition=fundamental","pubTime":"2026-09-06 17:04","pubTimestamp":1788685454,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH) has announced that its controlling subsidiary, Fosun Pharma Singapore, executed a share sale of Gland Pharma shares on September 4, 2026...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600196","BK1515","BK0183","BK0196","BK0188","BK0239","BK0028","BK1191","BK0175","BK0060","BK0187","BK0012","BK1593","BK0096","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129259024","title":"Dizhe Pharma Stock Drops Over 5% After Insider Sell-Off Plan; Company Affirms Long-Term Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1129259024","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129259024?lang=en_us&edition=fundamental","pubTime":"2026-09-06 15:11","pubTimestamp":1788678679,"startTime":"0","endTime":"0","summary":"Dizhe Pharma (also known as Dizhe Pharmaceutical) saw its share price tumble more than 5% on Thursday, September 4th, following a disclosure that four senior executives plan to reduce their holdings...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","BK1161","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144923293","title":"ALEBUND-B (09637) H Shares Set to Join Stock Connect and Hang Seng Composite Index","url":"https://stock-news.laohu8.com/highlight/detail?id=1144923293","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144923293?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:36","pubTimestamp":1788528973,"startTime":"0","endTime":"0","summary":"The Board of ALEBUND-B (09637) has announced that its H shares have been included in the list of eligible securities under the Stock Connect programme. This inclusion will take effect from Monday,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159938","BK1161","BK1574","09637","BK1515","HSCI","FLHK","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664204332","title":"Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping","url":"https://stock-news.laohu8.com/highlight/detail?id=2664204332","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664204332?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:30","pubTimestamp":1788528637,"startTime":"0","endTime":"0","summary":"Wuhan Dazhong Dental proposes Wang Hong as executive director to replace Guo JiapingWuhan Dazhong Dental Medical proposed appointing vice general manager Wang Hong as an executive director, pending sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDLbWh1cr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","IE000MB6IJN5.SGD","LU1057294990.SGD","LU1244550577.SGD","IE00BLSP4239.USD","LU0943347566.SGD","BK1515","IE00BZ08YR35.GBP","LU2750360997.AUD","LU1732799900.SGD","LU0058720904.USD","02651","VHT","LU1929549753.HKD","LU1066051498.USD","PJP","RXL","JNJ","XLV","LU2471134523.USD","SG9999001440.SGD","IHE","LU0345769128.USD","MEDX","JDOC","LU0820561909.HKD","IXJ","BMED","IE0002141913.USD","FHLC","IE00BDGV0183.EUR","LU1894683264.USD","LU1061106388.HKD","LU0234572021.USD","LU1894683348.USD","GDOC","LU2430703251.USD","LU2756315664.SGD","LU2430703178.SGD","FTXH","IE00B3T34201.USD","IYH","LU0792757196.USD","LU0820562030.AUD","TRUH","LU0964807845.USD","LU0912757837.SGD","LU1551013342.USD","01177","LU2592432038.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185361801","title":"Junshi Biosciences Schedules 2026 Interim Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=1185361801","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185361801?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:13","pubTimestamp":1788527603,"startTime":"0","endTime":"0","summary":"Junshi Biosciences (also known as JUNSHI BIO) has announced it will hold a conference call to discuss its 2026 interim financial results on September 14, 2026.According to the company's latest...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877","BK1583","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103371342","title":"Traditional Chinese Medicine Firm Secures Regulatory Approval for New Depression Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1103371342","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103371342?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:54","pubTimestamp":1788526459,"startTime":"0","endTime":"0","summary":"TRAD CHI MED (00570) has announced that its subsidiary, Guizhou Tongjitang Pharmaceutical Co., Ltd., has received official market authorization from the National Medical Products Administration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1161","BK1606","IPOS","BK1574","MEDX","159992","BK1515","BK1191","00570","IBBQ","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664334921","title":"China Traditional Chinese Medicine Says NMPA Approves Launch of Xingpi Jieyu Tablets for Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2664334921","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664334921?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:46","pubTimestamp":1788525998,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine says NMPA approves launch of Xingpi Jieyu tablets for depressionChina Traditional Chinese Medicine Holdings said China’s NMPA cleared its Class 1.1 TCM innovative dr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6dF7Rm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570","BK1515","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664349413","title":"China Traditional Chinese Medicine Holdings - Nmpa Approves Xingpi Jieyu Tablets for Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664349413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664349413?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:46","pubTimestamp":1788525987,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44W0SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1606","BK1515","00570","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803133","title":"Sinopharm Group Stock Advances 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803133","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803133?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:33","pubTimestamp":1788510780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 1.5% to 15.69 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.This was the stock's second consecutive day of gains.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.4%.Trading volume totaled 9.2 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0175","BK0187","BK0096","SHTDY","LU0640798160.USD","BK1593","LU1115378108.SGD","BK0028","BK0239","BK0196","02196","BK1191","BK1500","BK1515","01099","BK4175","BK1197","BK0060","BK0183","600196","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664138039","title":"JD Health International Stock Rallies 2.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138039?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:32","pubTimestamp":1788510720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. advanced 2.9% to 37.06 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.JD Health International Inc. closed 48% below its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 7.4 million shares, compared to the 50-day average of 10.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1615","BK1515","06618","LU0456827905.SGD","LU0051755006.USD","BK1247","86618","BK1589","BK1571","BK1142","SGXZ62798434.SGD","BK1591","SGXZ86797644.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803883","title":"Alibaba Health Information Technology Stock Climbs 3.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803883","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803883?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:31","pubTimestamp":1788510660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. rose 3.3% to 3.14 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.The stock's rise snapped a four-day losing streak.Alibaba Health Information Technology Ltd. closed 60% below its 52-week high of HK$7.91, which the company reached Jan. 14.The stock outperformed some of its competitors, as HKT Trust & HKT Ltd. rose 1.4%.Trading volume totaled 67.4 million shares, compared to the 50-day average of 102.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["83115","BK1247","03419","03037","03115","BK1515","02800","02833","HK0000165453.HKD","HSI","513600","BK1615","BK1589","BK1189","07500","MCHmain","BK1142","MHImain","82800","07300","HHImain","BK1501","BK1617","00241","BK1584","BK1591","BK1571","BK1610","07200","09115","BK1502","HSTECH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130149343","title":"DBS lifts BYD Electronic price target to HK$40, reiterates 'Buy'","url":"https://stock-news.laohu8.com/highlight/detail?id=1130149343","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130149343?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:26","pubTimestamp":1788510375,"startTime":"0","endTime":"0","summary":"DBS has released a research report stating it has raised the target price for BYD Electronic (00285) from HK$30 to HK$40, while maintaining a \"Buy\" rating. The bank has extended its valuation base to...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1607","BK1580","BK1589","LU0348767384.USD","BK1540","LU0348766576.USD","BK1515","00285","BK1582","BK1167","LU0274383008.USD","BK1504","BK1149","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183163431","title":"Healthcare Sector Poised for Continued Recovery, Buoyed by Strong Innovation and Upgraded Earnings Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=1183163431","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183163431?lang=en_us&edition=fundamental","pubTime":"2026-09-04 15:16","pubTimestamp":1788506182,"startTime":"0","endTime":"0","summary":"According to a research report from BOCOM INTL, the Hong Kong-listed healthcare sector charted an independent course in August, with the Hang Seng Healthcare Index climbing 9.3% against a 1.2%...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","ZECP","09939","03329","159938","BK1147","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117075643","title":"Hong Kong Stock Exchange Data Reveals Significant Custody Transfer for GENFLEET-B","url":"https://stock-news.laohu8.com/highlight/detail?id=1117075643","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117075643?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:12","pubTimestamp":1788484341,"startTime":"0","endTime":"0","summary":"According to the latest disclosure from the Hong Kong Stock Exchange, a notable change in share custody was recorded on September 3rd for GENFLEET-B (02595). The total market value of the shares held...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","02595","BK1161","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664028698","title":"Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664028698","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664028698?lang=en_us&edition=fundamental","pubTime":"2026-09-04 06:07","pubTimestamp":1788473269,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical (HKG:1177) unit Chia Tai Tianqing Pharmaceutical Group obtained investigational new drug approval for TQB6426 from the U.S. Food and Drug Administration.The drug is intended for advanced malignant tumors, according to a Thursday Hong Kong bourse filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","HK0000165453.HKD","LABU","BK1521","IE00BZ08YS42.EUR","BK4585","BK1589","BK4588","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1515","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118066289","title":"Baiyunshan Announces Cash Dividend Distribution for First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1118066289","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118066289?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:41","pubTimestamp":1788446515,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (also known as BAIYUNSHAN PH) disclosed on September 3 that it will execute its interim dividend payout for the 2026 fiscal first...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","BK0183","BK1515","BK1521","BK1191","BK0097","BK0070","BK0196","00874","BK1606","BK0188","BK0028","600332","BK0096","BK0239","BK1197","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664033874","title":"Sino Biopharm Says FDA Clears IND for Tqb6426 GPC3 ADC Trial in Advanced Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664033874","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664033874?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:39","pubTimestamp":1788439175,"startTime":"0","endTime":"0","summary":"Sino Biopharm says FDA clears IND for TQB6426 GPC3 ADC trial in advanced tumorsFDA granted IND clearance for TQB6426, a GPC3-targeting antibody-drug conjugate from Sino Biopharmaceutical’s Chia Tai Ti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL2vynvZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","BK1191","01177","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","HK0000165453.HKD","IE00BZ08YT58.USD","BK1515","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874083","title":"Sino Biopharmaceutical - Application for Clinical Trial on Tqb6426 \"Gpc3 ADC\" Approved by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874083?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:39","pubTimestamp":1788439159,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V15X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1521","BK1191","HK0000165453.HKD","01177","IE00BZ08YT58.USD","BK1589","IE00BZ08YR35.GBP","BK1515","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188828400","title":"Executive Wang Lei Boosts Stake in China Resources Mixc Lifestyle with Fresh Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1188828400","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188828400?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:34","pubTimestamp":1788435276,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange filings reveal that on September 1, Wang Lei increased his holdings in CHINA RES MIXC (01209) by 50,000 shares. The transaction was executed at a price of HKD 38.52 per...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456827905.SGD","BK1589","HK0000165453.HKD","BK1542","BK1584","LU0082770016.SGD","BK1189","BK1583","BK1617","LU0051755006.USD","BK1610","EWH","BK1258","LU0620787316.HKD","BK1615","BK1247","LU0456846285.SGD","BK1142","BK1502","BK1591","BK1501","00241","BK1515","BK1229","BK1571","01209","LU0164939612.USD","LU0082770016.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101393084","title":"GENFLEET-B Allocates HK$546,400 to Buy Back 20,000 Shares on September 3","url":"https://stock-news.laohu8.com/highlight/detail?id=1101393084","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101393084?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:24","pubTimestamp":1788434654,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on September 3, 2026, it spent HK$546,400 to repurchase 20,000 of its own shares.This buyback reflects the company's ongoing capital management strategy, as it...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1515","159938","BK1161","02595","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":185,"code":"91000000","status":"200"}]}}